SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410939-21-000021
Filing Date
2021-05-21
Accepted
2021-05-21 06:46:23
Documents
12
Period of Report
2021-05-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K isee-20210519.htm   iXBRL 8-K 50450
  Complete submission text file 0001410939-21-000021.txt   191813

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20210519.xsd EX-101.SCH 1933
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20210519_lab.xml EX-101.LAB 25298
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20210519_pre.xml EX-101.PRE 13207
5 EXTRACTED XBRL INSTANCE DOCUMENT isee-20210519_htm.xml XML 10989
Mailing Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001
Business Address 5 PENN PLAZA SUITE 2372 NEW YORK NY 10001 212-845-8200
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 21946574
SIC: 2834 Pharmaceutical Preparations